Survival after massive ecstasy overdose

Journal of Toxicology - Clinical Toxicology

Volumn 36, Issue 7, 1998, Pages 727-731

  Ramcharan, S ^a   Meenhorst, P L ^a   Otten, J M M B ^a   Koks, C H W ^a   De Boer, D ^b   Maes, R A A ^b   Beijnen, J H ^a,c  

^a SLOTERVAART HOSPITAL   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

^c NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ACTIVATED CARBON; ALCOHOL; AMPHETAMINE DERIVATIVE; CLONAZEPAM; DANTROLENE; DESIGNER DRUG; OXAZEPAM; PANCURONIUM BROMIDE;

ADULT; APNEA; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG INTOXICATION; DRUG OVERDOSE; FATALITY; HUMAN; HYPERTHERMIA; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FAILURE; MALE; ORAL DRUG ADMINISTRATION; RHABDOMYOLYSIS; TREATMENT OUTCOME; UNCONSCIOUSNESS;

EID: 0031699516     PISSN: 07313810     EISSN: None     Source Type: Journal    
DOI: 10.3109/15563659809162623     Document Type: Article

References (20)

1. Wake D. Ecstasy overdose: A case study. Intens Crit Care Nurs 1995;11:6-9.
2. Man de RA. Morbidity and mortality as a result of ecstasy consumption. Ned Tijdschr Geneeskd 1994; 138:1850-1855.
3. Randall T. Ecstasy-fueled "rave" parties become dances of death for English youths. JAMA 1992;268: 1505-1506.
4. Jones AL, Jarvie DR, McDermid G, Proudfoot AT. Hepatocellular damage following amphetamine intoxication. J Toxicol Clin Toxicol 1994;32:435-444.
5. Henry JA. Ecstasy and the dance of death. BMJ 1992;305:5-6.
6. Henry JA, Jeffreys KJ, Dawling S. Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy"). Lancet 1992;340:384-387.
7. Rittoo DB, Rittoo D, Ellis SJ, Lamer AJ. Complications of "ecstasy" misuse. Lancet 1992;340:725-726.
8. Squier MV, Jalloh S, Hilton-Jones D, Series H. Death after ecstasy ingestion: Neuropathological findings. J Neurol Neurosurg Psychiatry 1995;58:756-764.
9. rd Ed. Philadelphia: WB SaundersCompany, 1998:1257.
10. Rohrig TP, Prouty RW. Tissue distribution of methylenedioxymethamphetamine. J Anal Toxicol 1992;16:52-53.
11. Steele TD, McCann UD, Ricaurte GA. 3,4-Methylenedioxymethamphetamine (MDMA, "Ecstasy"): Pharmacology and toxicology in animals and humans. Addiction 1994;89:539-551.
12. Henderson GL. Designer drugs. In: Analytical Toxicology for Clinical, Forensic, and Pharmaceutical Ohemists. Brandenberger H, Maes RAA, eds., Berlin-New York: Walter de Gruyter, 1997:685-704.
13. Lim HK, Su Z, Foltz RL. Stereoselective disposition: Enantioselective quantitation of 3,4-(methylene dioxy) methamphetamine and three of its metabolites by gas chromatography/electron capture negative ion chemical ionization mass spectrometry. Biol Mass Spec 1993;22:403-411.
14. Dowling GP, Mc Donough ET, Bost RO. "Eve" and "ecstasy": A report of five deaths associated with the use of MDEA and MDMA. JAMA 1987;257:1615-1617.
15. Barrett PJ. "Ecstasy" misuse-overdose or normal dose? Anaesthesia 1993;48:83.
16. Ames D, Wirshing WC. Ecstasy, the serotonin syndrome, and neuroleptic malignant syndrome - a possible link? JAMA 1993;269:869-870.
17. Milroy CM, Clark JC, Forrest ARW. Pathology of deaths associated with "ecstasy" and "eve" misuse. J Clin Pathol 1996;49:149-153.
18. Miller DB, O'Callaghan JP. Environment-, drug-and stress-induced alterations in body temperature affect the neurotoxicity of substituted amphetamines in the C57BL/6J Mouse. J Pharmacol Exp Ther 1994;270: 752-760.
19. Dafters RI. Hyperthermia following MDMA administration in rats: Effects of ambient temperature, water consumption, and chronic dosing. Physiology Behavior 1995;58:877-882.
20. Mc Cann UD, Slate SO, Ricaurte GA. Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA;"Ecstasy"). Drug Safety 1996;15:107-115.